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Eur J Vasc Endovasc Surg (2009) 37, 497e499CORRESPONDENCELetter to the EditorWe read with interest the recent article entitled ‘‘Clinical
endpoints in peripheral endovascular revascularisation
trials: a case for standardized definitions’’.1 We agree that
there is a need to standardize outcome assessments but
believe that the authors’ have given insufficient impor-
tance to health-related quality of life tools. Patients with
intermittent claudication are the most common group to
receive peripheral endovascular revascularisation at many
centres, despite the current lack of clear evidence to show
this approach is more beneficial than conservative treat-
ment options that include exercise prescription.2,3 The
primary reason to treat individuals with this problem is to
improve their health-related quality of life, since the risk of
limb loss is low. Treadmill walking and haemodynamic tests
provide objective assessment of walking impairment but do
not assess the effect that such limitations have on an
individual patient’s life style, as discussed in detail in
a previous editorial.4 Intermittent claudication specific
health-related quality of life tools, such as the intermittent
claudication questionnaire5 have been developed and we
believe should be included (along with treadmill and hae-
modynamic testing) in uniform reporting guidelines such as
this recent report. The authors’ mention the use of the
EQ5D and the walking impairment questionnaire (WIQ) in
baseline assessment only and not as outcome measures.
EQED is a generic health-related quality of life tool and we
would be interested in the reasoning for selecting this
instead of the SF-36, which is preferred by many investi-
gators,6 as it covers a wider range of health domains.6 The
WIQ is not normally considered a quality of life tool since
the questions relate specifically to walking distances and
not their effects on health-related quality of life.5 We
support further assessment of the value of endovascular
therapy in randomised trials and encourage the inclusion of
appropriate health-related quality of life tools as outcome
measures.
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Response to Letter to Editor
Sir,
The purpose of DEFINE group’s initiative was to arrive at
a broad-based consensus for baseline and end-pointDOI of original article: 10.1016/j.ejvs.2008.11.040.
